Medincell is a pharmaceutical technology company based in France that develops long-acting injectable formulations of medicines. Its technology uses biodegradable polymers to release drugs slowly in the body over extended periods, aiming to improve how patients take their treatments. The company works with pharmaceutical partners to develop and commercialise products in areas such as mental health and infectious disease, and it earns revenue through licensing and collaboration agreements rather than from selling medicines directly to patients.
The shares are listed on the Euronext Paris in France under the code MEDCL, and the price on this page is in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #256 of 625 on the Euronext Paris · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for France yet.
TrendFair
62/100
Mixed trend against its averages.
See the numbers →
Above 200-day average7.1%
From 52-week high-30.8%
MomentumFair
61/100
Typical recent returns for this exchange.
See the numbers →
3-month return2.3%
6-month return11.8%
12-month, skipping last month-36.6%
Stability (higher is calmer)Weak
32/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)56.5%
Worst drawdown, 1 year (smaller is calmer)-47.4%
LiquidityStrong
84/100
Trades actively.
See the numbers →
Avg daily value traded2.36M EUR
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for France when fundamentals data for this market is added. All France stocks.
52-wk range 19.69 – 39.68Daily closes, split-adjusted
Signals
50-day average24.26
200-day average24.85
Golden/death cross (60d)Death, 32 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1.44
Technical summary
Daily
Strongly bullish
11 bullish · 4 neutral · 1 bearish
Weekly
Strongly bullish
11 bullish · 1 neutral · 0 bearish
Monthly
Strongly bullish
6 bullish · 1 neutral · 1 bearish
Moving averages (daily)
SMA 10
26.28
Bullish
EMA 10
26.21
Bullish
SMA 20
25.89
Bullish
EMA 20
25.76
Bullish
SMA 50
24.26
Bullish
EMA 50
25.03
Bullish
SMA 100
25.20
Bullish
EMA 100
24.97
Bullish
SMA 200
24.85
Bullish
EMA 200
24.68
Bullish
Oscillators (daily)
RSI (14)
55.22
Neutral
MACD (12, 26)
0.65
Bullish
Momentum (12)
-8.47
Bearish
Stochastic %K (14)
27.02
Neutral
Williams %R (14)
-72.98
Neutral
CCI (20)
31.05
Neutral
Pivot points (classic, last session)
S3
25.35
S2
25.69
S1
26.15
Pivot
26.49
R1
26.95
R2
27.29
R3
27.75
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in EUR. Educational only, not financial advice.
